Zoetis Inc. (ETR: ZOE)
Market Cap | 72.73B |
Revenue (ttm) | 8.21B |
Net Income (ttm) | 2.18B |
Shares Out | n/a |
EPS (ttm) | 4.77 |
PE Ratio | 33.38 |
Forward PE | n/a |
Dividend | 1.60 (0.98%) |
Ex-Dividend Date | Jan 21, 2025 |
Volume | 78 |
Average Volume | 149 |
Open | 163.98 |
Previous Close | 163.52 |
Day's Range | 163.58 - 163.98 |
52-Week Range | 136.70 - 185.00 |
Beta | 0.90 |
RSI | 52.44 |
Earnings Date | Feb 14, 2025 |
About Zoetis
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives... [Read more]
Financial Performance
In 2023, Zoetis's revenue was $8.54 billion, an increase of 5.74% compared to the previous year's $8.08 billion. Earnings were $2.34 billion, an increase of 10.88%.
Financial numbers in USD Financial StatementsNews
3 Upcoming Dividend Increases
This week's anticipated dividend increases feature three companies with an average increase of 8.9% and a median increase of 8.7%. My strategy focuses on buying, holding, and adding companies that con...
Zoetis Inc. (ZTS) to Present at 43rd Annual J.P. Morgan Healthcare Conference
Zoetis Inc. (ZTS) to Present at 43rd Annual J.P. Morgan Healthcare Conference
Top 50 High Quality Dividend Growth Stocks - January 2025
I track 50 high-quality dividend stocks, updating their valuations daily to identify Strong Buy, Buy, Hold, and Trim opportunities based on historical free cash flow trends. Using my quality score and...
How Is The Market Feeling About Zoetis?
Zoetis's (NYSE: ZTS) short percent of float has risen 14.88% since its last report. The company recently reported that it has 6.26 million shares sold short , which is 1.39% of all regular shares tha...
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?
TROY, Mich. , Jan. 7, 2025 /PRNewswire/ -- Zoetis's recent report has investors wondering if the company's stock is overvalued.
Zoetis Inc (ZTS) Announces Upcoming Webcast for Q4 and Full Year 2024 Financial Results
Zoetis Inc (ZTS) Announces Upcoming Webcast for Q4 and Full Year 2024 Financial Results
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial O...
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 13, 2025. Chief Executive Officer Krist...
My Top 15 High Growth Dividend Stocks For January 2025
The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1...
Revisited: does the evidence on glucose tracking add up? – podcast
You might have noticed that everyone has recently become a bit obsessed with blood sugar, or glucose. Wellness firms such as Zoe in the UK – as well as Nutrisense, Levels and Signos – claim to offer i...
Dividends Matter - 3 Of My Favorite Stocks In An Overpriced Market
The market's lofty valuations make finding value tricky, but dividend stocks remain a beacon of stability and growth for long-term investors. I've identified three standout dividend stocks offering so...
The Wall Street Journal Vs. Zoetis
Debunking claims of safety concerns around Zoetis Inc.'s OA pain drug, Librela. Click here for our updated look at ZTS stock and a look ahead.
Zoetis dips as FDA cites adverse events linked to canine pain therapy Librela
Zoetis (ZTS) stock falls as FDA notifies about adverse events in dogs treated with the company's pain therapy Librela. Read more here.
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
Zoetis (NYSE: ZTS) has outperformed the market over the past 10 years by 4.24% on an annualized basis producing an average annual return of 15.83%. Currently, Zoetis has a market capitalization of $8...
Zoetis raises quarterly dividend by 16% to $0.50/share
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the first quarter of 2025, an increase of 16% from the quarterly dividend rate paid in 2024. The dividen...
Zoetis Declares First Quarter 2025 Dividend; Board Approves 16% Payment Increase
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.50 per share for the first quarter of 2025, an increase of 16% ...
Zoetis: Are Competition And Price Increases A Cause For Concern?
Zoetis is the market leader in a growing industry, and the numbers are starting to show its dominance. Click here to read an analysis of ZTS stock now.
The animal health industry is resilient, Zoetis CEO
Zoetis CEO Kristin Peck unpacks pet owners' concerns in caring for their beloved animals on 'The Claman Countdown.'
Zoetis Inc. (ZTS) Piper Sandler 36th Annual Healthcare Conference (Transcript)
How do I get out of a lease for a Renault electric car battery?
Reader says it is unfair she would have to pay £2,000 to buy the battery in her Zoe, or £400 to have it removed I own an eight-year-old Renault Zoe and lease the battery for £50 a month from Mobilize ...
My Top 15 High-Growth Dividend Stocks For December 2024
The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a...
Zoetis: Healing Paws, Growing Profits
Zoetis Inc. (ZTS) Management presents at Jefferies London Healthcare Conference (Transcript)
Zoetis to Participate in the Piper Sandler 36th Annual Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, E...